CG Oncology, Inc.

NasdaqGS:CGON Stock Report

Market Cap: US$2.0b

CG Oncology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:CGON Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
29 Jan 24BuyUS$38,000Corleen RocheIndividual2,000US$19.00
29 Jan 24BuyUS$24,985Vijay KasturiIndividual1,315US$19.00
29 Jan 24BuyUS$4,999,983Hong Fang SongIndividual263,157US$19.00
29 Jan 24BuyUS$15,200,000Decheng Capital LLCCompany800,000US$19.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CGON?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,011,2301.52%
Public Companies3,543,5335.32%
Individual Insiders4,714,7067.07%
VC/PE Firms13,691,29720.5%
General Public15,470,17023.2%
Institutions28,209,21442.3%

Dilution of Shares: CGON only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 67.65% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.19%
Decheng Capital LLC
5,458,810US$163.7m19.7%17.92%
7%
Longitude Capital Management Co., LLC
4,662,281US$139.8m12%29.94%
6.82%
Hong Fang Song
4,544,104US$136.2m6.15%no data
5.36%
TCG Crossover Management, LLC
3,570,206US$107.0m28.9%8.46%
5.32%
Kissei Pharmaceutical Co., Ltd.
3,543,533US$106.2m0%no data
3.78%
BlackRock, Inc.
2,518,550US$75.5m0%no data
3.34%
The Vanguard Group, Inc.
2,225,018US$66.7m0%no data
2.83%
BVF Partners L.P.
1,884,191US$56.5m0%1.51%
2.55%
T. Rowe Price Group, Inc.
1,700,829US$51.0m0%no data
2.28%
Janus Henderson Group plc
1,521,432US$45.6m6,120%0.02%
2.18%
Avidity Partners Management, L.P.
1,454,765US$43.6m0%1.5%
1.96%
Perceptive Advisors LLC
1,304,105US$39.1m0%0.7%
1.85%
Ally Bridge Group
1,235,879US$37.1m0%14.85%
1.7%
Braidwell LP
1,130,235US$33.9m0%1.86%
1.52%
Unique Diamond Investments Limited
1,011,192US$30.3m0%no data
1.4%
AllianceBernstein L.P.
929,752US$27.9m0%0.01%
1.27%
Franklin Resources, Inc.
843,492US$25.3m0%0.01%
1.2%
Cormorant Asset Management, LP
800,000US$24.0m0%1.09%
1.16%
Frazier Life Sciences Management, LP
770,000US$23.1m0%0.87%
1.15%
Holocene Advisors, LP
766,625US$23.0m0%0.08%
1.09%
Polar Capital Holdings Plc
729,166US$21.9m0%0.08%
1.05%
Avoro Capital Advisors LLC
700,000US$21.0m0%0.24%
1.04%
Foresite Capital Management, LLC
692,550US$20.8m-75%6.98%
0.84%
Millennium Management LLC
558,197US$16.7m0%0.01%
0.79%
Woodline Partners LP
525,199US$15.7m0%0.14%
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.